Parazole 10% w/v Oral Suspension

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Fenbendazole

Διαθέσιμο από:

Foran Healthcare Limited

Φαρμακολογική κατηγορία (ATC):

QP52AC13

INN (Διεθνής Όνομα):

Fenbendazole

Δοσολογία:

10 percent weight/volume

Φαρμακοτεχνική μορφή:

Oral suspension

Τρόπος διάθεσης:

CAM: Companion Animal Medicine as defined in relevant national legislation

Θεραπευτική ομάδα:

Cats, Dogs

Θεραπευτική περιοχή:

fenbendazole

Θεραπευτικές ενδείξεις:

Endoparasiticide

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

1997-10-01

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Parazole 10% w/v Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral suspension.
A white to off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for the treatment of domestic dogs and
cats infected with immature and mature stages of
nematodes of the gastrointestinal and respiratory tracts.
Effective against immature and mature ascarids, hookworms and
tapeworms. Also kills roundworm eggs.
4.3 CONTRAINDICATIONS
Do not use in case of known hypersensitivity to the active substance
or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals:
Ensure correct weight estimation and dose calculation.
Special precautions to be taken by the person administering the
product to animals:
Avoid contact with the product.
Wash hands after use.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known .
Each ml contains:
Active substance
Fenbendazole
100 mg
Excipients
Methyl Parahydroxybenzoate
2.5 mg
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_2_
_/_
_0_
_2_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_8_
_2_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Pregnan